Founded in 1991 and headquartered in Itapevi, Brazil, the two businesses generated sales of approximately €11 million in 2023.

The transaction, for which financial details were not disclosed, is expected to close in quarter four of 2024, subject to customary conditions

Torsten Walz, global president Pharma of Brenntag's Specialties business unit, said:“PIC and PharmaSpecial have built a broad portfolio of world-class suppliers and value-added services which are highly compatible with our global Pharma strategy. I look forward to growing our business in the region to expand on this foundation.”

This acquisition in Latin America, Brenntag said, is also an opportunity to expand the company’s global network of application & innovation centers. In addition, the German distribution giant gains entry into the soft gel capsule market.

“Joining Brenntag is a wonderful opportunity to grow what we have built,” commented Fabio Morais, CEO of PIC and PharmaSpecial. “Our dedicated team will be able to better serve our regional customers with the global expertise and network of application & innovation centers we gain from Brenntag. This gives our supply partners a significant global reach.”